Related Experiment Video
Updated: Nov 7, 2025

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation
Published on: June 17, 2015
Open Science in regulatory environmental risk assessment
Theo C M Brock1, Kevin C Elliott2,3, Anja Gladbach4
1Wageningen Environmental Research, Wageningen, The Netherlands.
Open Science in regulatory environmental risk assessment (ERA) increases transparency and public trust. Embracing Open Science principles offers significant benefits that outweigh potential risks for all stakeholders involved in ERA.
Area of Science:
- Environmental Science
- Risk Assessment
- Regulatory Science
Background:
- Public skepticism towards regulatory science can be reduced through increased transparency.
- Open Science principles offer a framework for enhancing this transparency.
Purpose of the Study:
- To discuss the opportunities and challenges of strengthening Open Science in regulatory environmental risk assessment (ERA).
- To argue that the benefits of Open Science in regulatory ERA outweigh its perceived risks.
Main Methods:
- Discussion paper format.
- Analysis of stakeholder roles and communication strategies.
Main Results:
- Open Science initiatives present significant opportunities for regulatory ERA.
- Stakeholders, including government, industry, academia, and NGOs, play crucial roles.
- Professional organizations can promote data reliability and communication.
Conclusions:
- The benefits of Open Science in regulatory ERA significantly outweigh the risks.
- Collaborative efforts are needed to implement Open Science effectively.
- Improved transparency in ERA builds public trust and understanding.
More Related Videos
08:00Screening for Endocrine Activity in Water Using Commercially-available In Vitro Transactivation Bioassays
Published on: December 4, 2016
05:47In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
Published on: August 28, 2019
Related Concept Videos
Global Regulatory Systems
Drug Control Governance: Regulatory Bodies and Their Impact
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Regulation
Design Example: Analyzing Capacity Contours for Flood Risk Assessment